Part,  Chapter, Paragraph

 1   II,     5.  2.  6|            130/80, if feasible, in diabetic or patients with established
 2   II,     5.  4.  1|       Microvascular complications (diabetic retinopathy, nephropathy
 3   II,     5.  4.  1|   representing the majority of the diabetic population:~ ~·Type 1 diabetes
 4   II,     5.  4.  1|     percentage of about 10% of the diabetic population is affected by
 5   II,     5.  4.  1|            almost 80% of the total diabetic population resides in developing
 6   II,     5.  4.  2|            active partnership with diabetic citizens, their families,
 7   II,     5.  4.  2|      linkage with other databases: diabetic patients may be identified
 8   II,     5.  4.  2|         pharmaceutical use made by diabetic patients.~A limitation of
 9   II,     5.  4.  2|      incidence of blindness due to diabetic retinopathy/total annual
10   II,     5.  4.  2|      incidence of blindness due to diabetic retinopathy is defined as
11   II,     5.  4.  2|       blindness in one year due to diabetic retinopathy/total number
12   II,     5.  4.  2|         100,000 individuals in the diabetic population in one year.~
13   II,     5.  4.  2|        transplantation per 100.000 diabetic population is defined as
14   II,     5.  4.  2|         100,000 individuals in the diabetic population.~Mortality is
15   II,     5.  4.  2|   exception of diabetes coma, most diabetic patients die from macrovascular
16   II,     5.  4.  2|         complications~ ~Percent of diabetic subjects and a HbA1c tested
17   II,     5.  4.  2|            12 months~16~Percent of diabetic subjects and a HbA1c tested,
18   II,     5.  4.  2|           HbA1c>7.5%~14~Percent of diabetic subjects with a lipid profile
19   II,     5.  4.  2|            12 months~14~Percent of diabetic subjects tested in the last
20   II,     5.  4.  2| cholesterol>5 mmol/l~14~Percent of diabetic subjects tested in the last
21   II,     5.  4.  2|            3 mmol/l)~13~Percent of diabetic subjects tested in the last
22   II,     5.  4.  2|            0 mmol/l)~11~Percent of diabetic subjects tested in the last
23   II,     5.  4.  2|            0 mmol/l)~12~Percent of diabetic subjects tested for microalbuminuria
24   II,     5.  4.  2|            12 months~12~Percent of diabetic subjects with a tested microalbuminuria
25   II,     5.  4.  2|       abnormal level~11~Percent of diabetic subjects with a tested blood
26   II,     5.  4.  2|            months~14~Percent of of diabetic subjects with a tested blood
27   II,     5.  4.  2|        value >140/90~10~Percent of diabetic subjects who are smoking~
28   II,     5.  4.  2|          are smoking~14~Percent of diabetic subjects and a BMI 25 kg/
29   II,     5.  4.  2|         complications~ ~Percent of diabetic subjects with fundus inspection
30   II,     5.  4.  2|            12 months~11~Percent of diabetic subjects tested in the last
31   II,     5.  4.  2|        last 12 months~6~Percent of diabetic subjects who received laser
32   II,     5.  4.  2|           retinopathy~1~Percent of diabetic subjects tested serum creatinine
33   II,     5.  4.  2|            12 months~13~Percent of diabetic subjects with ESRF serum
34   II,     5.  4.  2|          traumatic but medical) in diabetic patients /100,000 general
35   II,     5.  4.  2|      Annual incidence of stroke in diabetic patients /100,000 general
36   II,     5.  4.  2|           myocardial infarction in diabetic patients/100,000 general
37   II,     5.  4.  2|            percentage of the total diabetic population that had their
38   II,     5.  4.  2|            the percentage of total diabetic population with HbA1c tested
39   II,     5.  4.  2|        parameter for lipids in the diabetic population. It is measured
40   II,     5.  4.  2|            the percentage of total diabetic population that had their
41   II,     5.  4.  2|      measured as the percentage of diabetic population with their total
42   II,     5.  4.  2|           by the percentage of the diabetic population that had their
43   II,     5.  4.  2|           as the percentage of the diabetic population with LDL-cholesterol
44   II,     5.  4.  2|           by the percentage of the diabetic population that had their
45   II,     5.  4.  2|           as the percentage of the diabetic population with their HDL-cholesterol
46   II,     5.  4.  2|        parameter for lipids in the diabetic population. It is measured
47   II,     5.  4.  2|            the percentage of total diabetic population that had their
48   II,     5.  4.  2|      measured as the percentage of diabetic population with their total
49   II,     5.  4.  2|            the percentage of total diabetic population that had microalbuminuria
50   II,     5.  4.  2|      measured as the percentage of diabetic population with microalbuminuria/
51   II,     5.  4.  2|          through the percentage of diabetic subjects that had their
52   II,     5.  4.  2|      measured as the percentage of diabetic subjects that had their
53   II,     5.  4.  2|       percentage of smokers in the diabetic population.~Levels of BMI
54   II,     5.  4.  2|      measured as the percentage of diabetic population that had their
55   II,     5.  4.  2|      measured by the percentage of diabetic population that had their
56   II,     5.  4.  2|       defined as the percentage of diabetic population that had their
57   II,     5.  4.  2|       defined as the percentage of diabetic population that had their
58   II,     5.  4.  2|       defined as the percentage of diabetic population that had their
59   II,     5.  4.  2|      measured as the percentage of diabetic population with creatinine
60   II,     5.  4.  2|         100,000 individuals in the diabetic population in one year.
61   II,     5.  4.  2|         100,000 individuals in the diabetic population in one year.~
62   II,     5.  4.  2|         100,000 individuals in the diabetic population in one year.~ ~
63   II,     5.  4.  3|      incidence of blindness due to diabetic retinopathy. EUCID found
64   II,     5.  4.  3|        transplantation per 100.000 diabetic population. Across 11 countries,
65   II,     5.  4.  3|       defined as the percentage of diabetic population that had their
66   II,     5.  4.  7|        clinical setting, where the diabetic patient is met and where
67   II,     5.  7.  3|        higher US incidence rate of diabetic ESRD.~ ~Table 5.7.3. Incidence
68   II,     5.  7.  3|           the incidence of RRT for diabetic and hypertensive ESRD became
69   II,     5.  7.  3|         incidence rates of RRT for diabetic and hypertensive ESRD (Stengel
70   II,     5.  7.  3|         incidence rates of RRT for diabetic and hypertensive ESRD (Stengel
71   II,     5.  7.  4|         incidence rates of RRT for diabetic ESRD and differences in
72   II,     8.  2.  2|           Table 8.3). Glaucoma and diabetic retinopathy are also significant
73   II,     8.  2.  2|           Table 8.3). Glaucoma and diabetic retinopathy are also significant
74   II,     9.  3.  1|         stress and hypertension in diabetic women (European Heart Network,